mardi 1 décembre 2015

Onco Actu du 1er décembre 2015

1. Biologie

BRCA1 Linked to Alzheimer’s [The Scientist]

DNA repair factor linked to breast cancer may also play a role in Alzheimer’s disease [National Institutes of Health]

3.1 Tabac

Cancer Research UK responds to BBC Panorama claims of wrong doing by British American Tobacco in Africa [Cancer Research UK]

Researching the Safety and Effectiveness of Electronic Nicotine Delivery Systems: What Have We Learned? [CANCER RESEARCH Catalyst]

4.10 Dép., diag. & prono. - Poumon

Lung cancer experts call for improved EGFR mutation testing to allow all eligible NSCLC patients access to personalised treatment [Boehringer Ingelheim]

4.2 Dép., diag. & prono. - Génome

Cancer’s genetic tipping point reveals who’d benefit from chemo [New Scientist]

4.9 Dép., diag. & prono. - Sein

This Nuclear Physicist Is Using Her Skills and Passion to Build a Better Mammography Machine [GE Reports]

5. Traitements

The American Society of Hematology and McMaster University Announce Partnership to Develop Clinical Practice Guidelines on Venous Thromboembolism [ASH]

Lung Cancer Precision Medicine Trials [National Cancer Institute]

5.2.2 Pharma - Fusions & Acquisitions

Pfizer: One Step Ahead of the Mudslide [In the Pipeline]

5.2.3 Pharma - économie

The Economist’s Take On Drug Discovery [In the Pipeline]

5.3 Traitements - FDA, EMA,...

Law for rare disease drugs needs revamping, researchers say [STAT]

5.3.4 Traitements - AMM (FDA, EMA)

Bristol-Myers Squibb and AbbVie Receive FDA Approval of Empliciti™ (elotuzumab) for the Treatment of Patients with Multiple Myeloma Who Have Received One to Three Prior Therapies [BMS]

FDA approves new Bristol-Myers treatment for multiple myeloma [Reuters]

FDA approves Empliciti, a new immune-stimulating therapy to treat multiple myeloma [FDA]

5.8.2 ASH - Pharma

New Data from Bayer’s Portfolio in Thrombosis, Hematology, and Oncology to be Presented at ASH 2015 [Bayer]

Juno Therapeutics Announces Data Presentations at the American Society of Hematology Annual Meeting [Juno Therapeutics]

Novartis highlights clinical advances at ASH 2015, underscoring leadership in hematology research [Novartis]

Bristol-Myers Squibb to Present New Data across Multiple Blood Cancers at the 57th Annual Meeting & Exposition of the American Society of Hematology [BMS]

6. Lutte contre les cancers

Cancer patients may benefit from mindfulness-based therapy [Reuters]

The Francis Crick Institute: science and serendipity [Times Higher Supplement]

6.10 Politiques

Many in Congress invest in companies they'll affect with votes [STAT]

6.7 DMP, Big Data & applis

Five Key Issues For The Future Of Cancer IT [Forbes]